Physician profile
John A Isch
NPI 1740289255
$10,559.19
in general payments reported to CMS, 2019-2025
21 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $67.68 · 2021: $131 · 2022: $8,636 · 2023: $524 · 2024: $532 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,471.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,342.71 | 2022-2023 | |
| Tela Bio, INC. | $456.43 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medtronic, INC. | $198.78 | 2022-2024 | Endoflip, Progrip, Dextile |
| Baxter Healthcare | $167.41 | 2021-2022 | |
| Becton, Dickinson and Company | $149.09 | 2025 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $147.32 | 2022-2023 | |
| Total Joint Orthopedics, INC. | $139.40 | 2019 | |
| Teleflex LLC | $137.45 | 2024 | Arrow |
| Kerecis Limited | $134.45 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Haemonetics Corporation | $117.00 | 2023 | Teg6s Hemostasis System |
| Stryker Corporation | $113.32 | 2019 | |
| Ethicon US, LLC | $103.16 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.05 | 2023-2025 | Gattex |
| Integra Lifesciences Corporation | $73.41 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| W. L. Gore & Associates, INC. | $53.42 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $42.37 | 2022 | |
| Convatec INC. | $32.13 | 2024 | |
| Innocoll Pharmaceuticals Limited | $17.76 | 2021 | |
| Sanara Medtech INC. | $14.68 | 2021 | |
| Novo Nordisk INC | $14.50 | 2024 | Wegovy |
| Biocomposites INC | $14.35 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Isch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.